A256 DETERMINATION OF PROTEOMIC SIGNATURE OF RESPONSE TO NEOADJUVANT RADIO-CHEMOTHERAPY IN COLORECTAL CANCER PATIENTS

BACKGROUND: Neoadjuvant radio-chemotherapy (NRCT) is current standard care for patients with colorectal cancer (CRC). Patients are often diagnosed late with locally advanced tumor completely invading wall of rectum (T3) or peripheral tissues or organs (T4), or if regional lymph node metastases are f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Can Assoc Gastroenterol
Main Authors: Chauvin, A, Mathieu, A, Lacasse, V, Wang, C, Geha, S, Garde-Granger, P, Boisvert, F
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Poster Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507682/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.257
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados